{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:44:19Z","timestamp":1790300659364,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of intra-peritoneal mediators in the regulation peritoneal transport is not completely understood. We investigate the relation between longitudinal changes in dialysis effluent level of nuclear factor kappa-B (NF-\u03baB) downstream mediators and the change in peritoneal transport over 1 year. We studied 46 incident PD patients. Their peritoneal transport characteristics were determined after starting PD and then one year later. Concomitant dialysis effluent levels of interleukin-6 (IL-6), cyclo-oxygenase-2 (COX-2) and hepatocyte growth factor (HGF) are determined. There were significant correlations between baseline and one-year dialysis effluent IL-6 and COX-2 levels with the corresponding dialysate-to-plasma creatinine level at 4\u2009hours (D\/P4) and mass transfer area coefficient of creatinine (MTAC). After one year, patients who had peritonitis had higher dialysis effluent IL-6 (26.6\u2009\u00b1\u200917.4 vs 15.1\u2009\u00b1\u200912.3\u2009pg\/ml, p\u2009=\u20090.037) and COX-2 levels (4.97\u2009\u00b1\u20096.25 vs 1.60\u2009\u00b1\u20091.53\u2009ng\/ml, p\u2009=\u20090.007) than those without peritonitis, and the number of peritonitis episode significantly correlated with the IL-6 and COX-2 levels after one year. In contrast, dialysis effluent HGF level did not correlate with peritoneal transport. There was no difference in any mediator level between patients receiving conventional and low glucose degradation product solutions. Dialysis effluent IL-6 and COX-2 levels correlate with the concomitant D\/P4 and MTAC of creatinine. IL-6 and COX-2 may contribute to the short-term regulation of peritoneal transport.<\/jats:p>","DOI":"10.1038\/s41598-020-63258-3","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:03:12Z","timestamp":1586944992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Longitudinal Changes of NF-\u03baB Downstream Mediators and Peritoneal Transport Characteristics in Incident Peritoneal Dialysis Patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Winston Wing-Shing","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Yam-Kau","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie Wai-Ki","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Fai","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie Ching-Ha","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis Mei-Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"63258_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1681\/ASN.2011060607","volume":"23","author":"AK Jain","year":"2012","unstructured":"Jain, A. K., Blake, P., Cordy, P. & Garg, A. X. Global trends in rates of peritoneal dialysis. J. Am. Soc. Nephrol. 23, 533\u2013544 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li, P. K. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13, 90\u2013103 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"63258_CR3","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/ndt\/gfn298","volume":"23","author":"O Devuyst","year":"2008","unstructured":"Devuyst, O. & Goffin, E. Water and solute transport in peritoneal dialysis, models and clinical applications. Nephrol. Dial. Transplant. 23, 2120\u20132123 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"63258_CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams, J. D. et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13, 470\u2013479 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00428-003-0963-3","volume":"444","author":"JA Jim\u00e9nez-Heffernan","year":"2004","unstructured":"Jim\u00e9nez-Heffernan, J. A. et al. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch. 444, 247\u2013256 (2004).","journal-title":"Virchows Arch."},{"key":"63258_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2003","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N. Engl. J. Med. 348, 403\u2013413 (2003).","journal-title":"N. Engl. J. Med."},{"key":"63258_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10753-009-9163-x","volume":"33","author":"RA Fock","year":"2010","unstructured":"Fock, R. A. et al. Effects of protein-energy malnutrition on NF-kappaB signalling in murine peritoneal macrophages. Inflammation. 33, 101\u2013109 (2010).","journal-title":"Inflammation."},{"key":"63258_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2369-15-8","volume":"15","author":"Y Cho","year":"2014","unstructured":"Cho, Y. et al. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol. 15, 8 (2014).","journal-title":"BMC Nephrol."},{"key":"63258_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/ndt\/gfp670","volume":"25","author":"KH Oh","year":"2010","unstructured":"Oh, K. H. et al. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol. Dial. Transplant. 25, 1639\u20131646 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"63258_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1681\/ASN.2008020211","volume":"20","author":"LS Aroeira","year":"2009","unstructured":"Aroeira, L. S. et al. Cyclooxygenase-2 Mediates Dialysate-Induced Alterations of the Peritoneal Membrane. J. Am. Soc. Nephrol. 20, 582\u2013592 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","volume":"20","author":"MA Yu","year":"2009","unstructured":"Yu, M. A. et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J. Am. Soc. Nephrol. 20, 567\u2013581 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cca.2016.11.020","volume":"464","author":"CC Szeto","year":"2017","unstructured":"Szeto, C. C. et al. Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. Clin. Chim. Acta. 464, 106\u2013112 (2017).","journal-title":"Clin. Chim. Acta."},{"key":"63258_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089686088700700306","volume":"7","author":"ZJ Twardowski","year":"1987","unstructured":"Twardowski, Z. J. et al. Peritoneal equilibration test. Perit. Dial. Bull. 7, 138\u2013147 (1987).","journal-title":"Perit. Dial. Bull."},{"key":"63258_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ndt\/12.1.184","volume":"12","author":"TW Mak","year":"1997","unstructured":"Mak, T. W. et al. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol. Dial. Transplant. 12, 184\u2013186 (1997).","journal-title":"Nephrol. Dial. Transplant."},{"key":"63258_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000169445","volume":"4","author":"RT Krediet","year":"1986","unstructured":"Krediet, R. T., Boeschoten, E. W., Zuyderhoudt, F. M., Strackee, J. & Arisz, L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purification. 4, 194\u2013203 (1986).","journal-title":"Blood Purification."},{"key":"63258_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PK Li","year":"2016","unstructured":"Li, P. K. et al. ISPD peritonitis recommendations, 2016 update on prevention and treatment. Perit. Dial. Int. 36, 481\u2013508 (2016).","journal-title":"Perit. Dial. Int."},{"key":"63258_CR17","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1681\/ASN.2013030314","volume":"24","author":"M Lambie","year":"2013","unstructured":"Lambie, M. et al. Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J. Am. Soc. Nephrol. 24, 2071\u20132080 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0165-2478(94)90142-2","volume":"41","author":"WM Pruimboom","year":"1994","unstructured":"Pruimboom, W. M. et al. Interactions between cytokines and eicosanoids, a study using human peritoneal macrophages. Immunol. Lett. 41, 255\u2013260 (1994).","journal-title":"Immunol. Lett."},{"key":"63258_CR19","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1182\/blood.V82.9.2853.2853","volume":"82","author":"E Shacter","year":"1993","unstructured":"Shacter, E., Arzadon, G. K. & Williams, J. A. Stimulation of interleukin-6 and prostaglandin E2 secretion from peritoneal macrophages by polymers of albumin. Blood. 82, 2853\u20132864 (1993).","journal-title":"Blood."},{"key":"63258_CR20","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1073\/pnas.93.10.4885","volume":"93","author":"RM Hinson","year":"1996","unstructured":"Hinson, R. M., Williams, J. A. & Shacter, E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation, possible role of cyclooxygenase-2. Proc. Natl Acad. Sci. USA 93, 4885\u20134890 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63258_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2369-15-201","volume":"15","author":"AP Bernardo","year":"2014","unstructured":"Bernardo, A. P. et al. Hepatocyte growth factor signalizes peritoneal membrane failure in peritoneal dialysis. BMC Nephrol. 15, 201 (2014).","journal-title":"BMC Nephrol."},{"key":"63258_CR22","first-page":"3543678","volume":"2016","author":"R Strippoli","year":"2016","unstructured":"Strippoli, R. et al. Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cell Int. 2016, 3543678 (2016).","journal-title":"Stem Cell Int."},{"key":"63258_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1165\/rcmb.2008-0217OC","volume":"40","author":"MN Shukla","year":"2009","unstructured":"Shukla, M. N. et al. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am. J. Respir. Cell Mol. Biol. 40, 643\u2013653 (2009).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"63258_CR24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1681\/ASN.V13196","volume":"13","author":"J Yang","year":"2002","unstructured":"Yang, J. & Liu, Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13, 96\u2013107 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63258_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ki.1995.36","volume":"47","author":"J Witowski","year":"1995","unstructured":"Witowski, J. et al. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int. 47, 282\u2013293 (1995).","journal-title":"Kidney Int."},{"key":"63258_CR26","unstructured":"Hulley, S. B., Cummings, S. R., Browner, W. S., Grady, D. G. & Newman, T. B. Designing clinical research, an epidemiologic approach, 4th ed. 79-80 (Lippincott Williams and Wilkins 2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63258-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:36:37Z","timestamp":1670319397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63258-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63258"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63258-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr CC Szeto receives research grant and consultancy from Baxter Healthcare. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6440"}}